United Therapeutics (UTHR) Misses Q2 EPS by 94c
Tweet
Share
E-mail
Get Alerts UTHR Hot Sheet
Price: $545.65 -1.24%
Revenue Growth %: +1.5%
Financial Fact:
Operating income: 238.6M
Today's EPS Names:
CCEL, FEIM, PLG, More
Revenue Growth %: +1.5%
Financial Fact:
Operating income: 238.6M
Today's EPS Names:
CCEL, FEIM, PLG, More
Join SI Premium – FREE
United Therapeutics (NASDAQ: UTHR) reported Q2 EPS of $6.41, $0.94 worse than the analyst estimate of $7.35. Revenue for the quarter came in at $798.6 million versus the consensus estimate of $804.98 million.
For earnings history and earnings-related data on United Therapeutics (UTHR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Baird on Nurix (NRIX) Earnings Amid 7% Drop: '2Q Print Solid as Breadth of Development Expands'
- Macquarie Double Upgrades Kinsus Interconnect Technology Corp (3189:TT) to Outperform
- U.S. issues new Iran-related sanctions
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
